Clinical Trials on Functional Pancreatic Neuroendocrine Tumor

Total 2 results

  • NCT02420691
    Completed
    Conditions: Advanced Digestive System Neuroendocrine Neoplasm, Duodenal Neuroendocrine Tumor G1, Functional Pancreatic Neuroendocrine Tumor, Gastric Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm, Low Grade Lung Neuroendocrine Neoplasm, Nonfunctional Pancreatic Neuroendocrine Tumor, Thymus Neoplasm
  • NCT02831179
    Withdrawn
    Conditions: Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Carcinoid Tumor, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B, Neuroendocrine Neoplasm, Non-Functional Pancreatic Neuroendocrine Tumor, Pancreatic Glucagonoma, Pancreatic Insulinoma, Recurrent Adrenal Cortex Carcinoma, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Merkel Cell Carcinoma, Somatostatin-Producing Neuroendocrine Tumor, Stage III Adrenal Cortex Carcinoma, Stage III Thyroid Gland Medullary Carcinoma, Stage IIIA Merkel Cell Carcinoma, Stage IIIB Merkel Cell Carcinoma, Stage IV Adrenal Cortex Carcinoma, Stage IV Merkel Cell Carcinoma, Stage IVA Thyroid Gland Medullary Carcinoma, Stage IVB Thyroid Gland Medullary Carcinoma, Stage IVC Thyroid Gland Medullary Carcinoma, Thymic Carcinoid Tumor, VIP-Producing Neuroendocrine Tumor, Well Differentiated Adrenal Cortex Carcinoma, Zollinger Ellison Syndrome